Catalym
catalym.com
Actively hiring
Cell & Gene Therapy
Biotechnology
Health Care
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Catalyzing immunotherapy. CatalYm has identified GDF-15 as a key cancer therapy resistance mechanism and is developing a safe and efficacious immune therapy for solid tumors.
Tech stack
Technologies named in job postings at Catalym over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
2
Stack modernity
74/100
Languages
Python
Cloud & platforms
GCP
Sign in to see how your skills match this stack
Sign In
People
Scott Clarke
Managing Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Growth
Hiring Momentum
48/100
Stable
Open positions
3
0 opened / 0 closed in 30 days
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
50%
QA
25% ▲
Operations
25% ▼